default author photo

Motohiro Tamiya

Osaka International Cancer Institute

SCHOLARLY PAPERS

3

DOWNLOADS

97

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Durvalumab with Etoposide and Carboplatin for Patients with Extensive-Stage Small Cell Lung Cancer and Interstitial Lung Disease: A Multicenter, Open-Label Prospective Trial

Number of pages: 28 Posted: 05 Aug 2024
Wakayama Medical University, Wakayama Medical University, Tohoku University - Tohoku University Hospital, Tohoku University, Saiseikai Utsunomiya Hospital, Saiseikai Utsunomiya Hospital, Saiseikai Kumamoto Hospital, Saiseikai Kumamoto Hospital, Wakayama Medical University, Hyogo Medical University, Osaka International Cancer Institute, Sendai Kousei Hospital, Itami City Hospital, Chiba University - Chiba University Hospital, Kobe City Medical Center General Hospital, Kurashiki Central Hospital - Department of Respiratory Medicine, Kumamoto University - Kumamoto University Hospital, Kinki-chuo Chest Medical Center, Kobe Minimally Invasive Cancer Center, Hyogo Prefectural Amagasaki General Medical Center, affiliation not provided to SSRN and Wakayama Medical University - Department of Pulmonary Medicine and Medical Oncology
Downloads 49 (1,074,648)

Abstract:

Loading...

chemoimmunotherapy, durvalumab, interstitial lung disease, pneumonitis, small-cell lung cancer

2.

Multicenter real-world data on first-line chemoimmunotherapy in patients with advanced non-small cell lung cancer and performance status 2: WJOG18424L

Number of pages: 45 Posted: 01 Oct 2025
affiliation not provided to SSRN, Juntendo University, Shizuoka Cancer Center, Juntendo University, Wakayama Medical University, Kindai University, Sendai Kousei Hospital, Kurashiki Central Hospital - Department of Respiratory Medicine, Kanagawa Cancer Center, affiliation not provided to SSRN, Kindai University, Niigata Cancer Center Hospital, Osaka International Cancer Institute, Kobe University, Kyushu University - Kyushu University Hospital, Kobe City Medical Center General Hospital, Kanagawa Cardiovascular and Respiratory Center, Kumamoto University - Kumamoto University Hospital, Hiroshima University - Hiroshima University Hospital, Nagasaki University, Wakayama Medical University - Department of Pulmonary Medicine and Medical Oncology, Kyushu University - Kyushu University Hospital and Juntendo University - Department of Respiratory Medicine
Downloads 29 (1,332,057)

Abstract:

Loading...

Non-small cell lung cancer, Performance status 2, Immune checkpoint inhibitors, Real-world evidence, First-line therapy

3.

Distinct long-term survival patterns associated with first-line systemic therapies in advanced NSCLC

Number of pages: 34 Posted: 31 Mar 2026
Osaka International Cancer Institute, Osaka International Cancer Institute, affiliation not provided to SSRN, Osaka International Cancer Institute, Osaka International Cancer Institute, Osaka International Cancer Institute, Osaka International Cancer Institute, Osaka International Cancer Institute, Osaka International Cancer Institute and Osaka International Cancer Institute
Downloads 19 (1,470,786)

Abstract:

Loading...

NSCLC, immunotherapy, EGFR-TKI, RMST, survival pattern